FDA Spars With Recalcitrant Compounding Pharmacy, Again
In an alert issued late last week, the took the unusual step of including a link to a 15-page inspection report that was completed July 16, showing numerous instances in which NuVision failed to investigate batches of various medicines after finding sterility problems. The noted in its alert that these medicines had been marketed to the public as ‘sterile.’
continue to read here
No comments:
Post a Comment